CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Understand the key moments to prioritize paying off debt versus investing. Optimize your financial strategy for success!
28,655 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Healthcare investing offers stability and growth potential in one package. This article compares SPDR Health Care (XL...
Ripple's latest private-market move values the company at $50 billion and signals confidence in its ecosystem, even a...
A new AI-driven forecast highlights two XRP price paths tied to a key CLARITY Act vote, with a possible surge to $5 o...
Bitcoin faces a renewed pullback, sliding toward $65K as crude oil and bond yields advance amid geopolitical tensions...
A wave of forgotten 401K plans now totals roughly 31.9 million accounts worth about $2.1 trillion, highlighting a stu...
Bitcoin trades near $81,000 as a decisive 72-hour window begins for the crypto market. Traders weigh ETF inflows, liq...
A top market analyst argues that heavily discounted altcoins may offer outsized upside as sentiment shifts, with Bitc...
Gold breaks above $4,770 as signs of de-escalation in global tensions ease inflation worries. Traders weigh safer hav...
As the Iran conflict intensified in early 2026, gold failed to rally as expected. A hypothetical $10,000 in gold woul...
Ripple-focused ETFs posted another week of net inflows even as XRP struggled to rally. The divergence highlights a sp...
IBM slumped 22% in early trading on a preliminary Q2 miss, igniting a wider tech sector selloff as analysts weigh AI ...